Detalhe da pesquisa
1.
Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry.
Mult Scler
; 27(14): 2254-2266, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33779361